ADDS Cognitive Impairment Screening Instrument

NegotiableUpdate on 05/06

Model

Nature of the Manufacturer: Producers

Product Category

Place of Origin

Online Consult

Overview

The ADDS cognitive impairment screening instrument uses a combination of graphic drawing parallel coordinate maps and radar maps to visualize and quantify EEG and behavioral control. Through real-time recording and point distribution calculation of the graphic drawing process, as well as variable scale singular value analysis and calculation of EEG physiological parameters in the time-frequency domain, it achieves the diagnosis and early risk assessment of Alzheimer's disease!

Product Details

Product Name:ADDS Cognitive Impairment Screening Instrument

Product type: Class II medical devices

Product Registration Certificate Number: Jixie Zhuzhun 20232070196

Product registration name: Cognitive Impairment Screening Device

Core positioning: Early screening equipment for cognitive impairment, solving the pain points of traditional screening that are difficult, slow, and accurate

Target audience: elderly people, high-risk groups for cognitive impairment, individuals with suspected symptoms of cognitive impairment (such as memory loss, language disorders, etc.)

Core technical parameters

Assessment mode: Dual dimensional assessment (international universal scale MMSE+MOCA+ADL+EEG monitoring)

Diagnostic accuracy: 95.65% (clinical diagnostic consistency rate)

Screening time: about 15 minutes

Operation mode: One click operation, head mounted electrode+touch screen interaction

Invasive: No harm, no puncture, no contrast agent

Core advantages (compared to traditional screening)

<ｉｆｒａｍｅ src=' https://about:blank/ ' frameborder='0' class='tb-scrollable-stunt' style='outline: none; -webkit-font-smoothing: antialiased; box-sizing: border-box; -webkit-tap-highlight-color: rgba(0, 0, 0, 0); border-width: 0px; border-style: solid; margin: 0px; padding: 0px; display: block; vertical-align: middle; height: 294px; left: -600px; position: absolute; top: -294px; user-select: none; visibility: hidden; width: 600px; '>

comparative dimension	Traditional screening	ADDS Cognitive Impairment Screening Instrument
Screening time	15-30 minutes/case	10-15 minutes/case
accuracy	About 70%	95.65%
Result presentation	Qualitative rating	Quantitative data+visual charts
invasiveness	Partial blood draw/imaging required	Non traumatic

Extended functionality

Closed loop management: linking ADTS memory impairment training system, ADMS cognitive neural regulation system, AI customized rehabilitation plan

Data management: electronic archive storage, multi center data sharing

Policy adaptation: in line with the requirements of the National Action Plan for the Prevention and Control of Alzheimer's Disease (2023-2025)

Applicable scenarios

Third class hospital: differential diagnosis of Alzheimer's disease (AD)

Primary healthcare: large-scale screening of community health service centers and township health centers

Specialized institutions: stroke center, rehabilitation hospital, nursing home (admission assessment, condition monitoring, annual screening)

Product Configuration and Services

Hardware configuration: Host+Head mounted EEG acquisition device

Software services: scale library, AI algorithm model; Remote technical training

Value added services: consultation on the full process solution of "screening intervention rehabilitation"; Assistance in Establishing a Cognitive Impairment Management Center

core value

Medical Value: Enhancing the Early Detection Rate of Cognitive Impairment and Supporting Early Intervention

Economic value: Reduce the cost of treating complications by 30% -50%, alleviate the pressure of medical and family care

Social Value: Supporting the Construction of Elderly Cognitive Health Prevention and Control System